Antibiotic use in the management of pulmonary nodules

Chest

Volumn 137, Issue 2, 2010, Pages 369-375

  Khokhar, Saira ^a   Mironov, Svetlana ^a   Seshan, Venkatraman E ^b   Stover, Diane E ^a   Khirbat, Rohit ^a   Feinstein, Marc B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE RESPIRATORY TRACT DISEASE; ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIECTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LUNG INFECTION; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT RESPONSE;

EID: 76749099254     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0562     Document Type: Article

References (25)

1. Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS; International Early Lung Cancer Action Program Investigators. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355(17):1763-1771.
2. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology. 2005;235(1):259-265.
3. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348(25):2535-2542.
4. Gould MK, Fletcher J, Iannettoni MD, et al; American College of Chest Physicians. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):108S-130S.
5. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354(9173):99-105.
6. Libby DM, Wu N, Lee IJ, et al. CT screening for lung cancer: the value of short-term CT follow-up. Chest. 2006;129(4):1039-1042.
7. Heo JN, Choi YW, Jeon SC, Park CK. Pulmonary tuberculosis: another disease showing clusters of small nodules. AJR Am J Roentgenol. 2005;184(2):639-642.
8. Eisenhuber E. The tree-in-bud sign. Radiology. 2002;222(3): 771-772.
9. Rossi SE, Franquet T, Volpacchio M, Giménez A, Aguilar G. Tree-in-bud pattern at thin-section CT of the lungs:radiologic-pathologic overview. Radiographics. 2005;25(3):789-801.
10. Ferrara I, Cappabianca S, Brunese L, et al. HRCT in detection of pulmonary infections from nontuberculous mycobacteria: personal experience. Radiol Med (Torino). 2009;114(3):376-389.
11. Tanaka D, Niwatsukino H, Oyama T, Nakajo M. Progressing features of atypical mycobacterial infection in the lung on conventional and high resolution CT (HRCT) images. Radiat Med. 2001;19(5):237-245.
12. Li Ng Y, Hwang D, Patsios D, Weisbrod G. Tree-in-bud pattern on thoracic CT due to pulmonary intravascular metastases from pancreatic adenocarcinoma. J Thorac Imaging. 2009;24(2):150-151.
13. Gould MK, Ananth L, Barnett PG;Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007;131(2):383-388.
14. McWilliams A, Mayo J. Computed tomography-detected noncalcified pulmonary nodules: a review of evidence for significance and management. Proc Am Thorac Soc. 2008;5(9):900-904.
15. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology. 2000;214(1):73-80.
16. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC; American College of Chest Physicians. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):94S-107S.
17. Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (< or 51 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. AJR Am J Roentgenol. 2003;180(4):955-964.
18. Kudoh S. Applying lessons learned in the treatment of diffuse panbronchiolitis to other chronic inflammatory diseases. Am J Med. 2004;117(Suppl 9A):12S-19S.
19. Rubin BK. Immunomodulatory properties of macrolides: overview and historical perspective. Am J Med. 2004;117(Suppl 9A):2S-4S.
20. Tamaoki J, Kadota J, Takizawa H. Clinical implications of the immunomodulatory effects of macrolides. Am J Med. 2004;117(Suppl 9A):5S-11S.
21. Wolter J, Seeney S, Bell S, Bowler S, Masel P, McCormack J. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax. 2002;57(3):212-216.
22. Garey KW, Alwani A, Danziger LH, Rubinstein I. Tissue reparative effects of macrolide antibiotics in chronic inflammatory sinopulmonary diseases. Chest. 2003;123(1):261-265.
23. King P. Is there a role for inhaled corticosteroids and macrolide therapy in bronchiectasis? Drugs. 2007;67(7):965-974.
24. Tsang KW, Ho PI, Chan KN, et al. A pilot study of low-dose erythromycin in bronchiectasis. Eur Respir J. 1999;13(2):361-364.
25. Stover DE, Mangino D. Macrolides: a treatment alternative for bronchiolitis obliterans organizing pneumonia? Chest. 2005;128(5):3611-3617.